Tag: cancer therapeutics

Regeneron and Telix Announce Strategic Radiopharma Collaboration

Regeneron and Telix Pharmaceuticals announce a strategic collaboration to develop next-generation radiopharmaceutical…

ME Desk

Pfizer Completes Licensing Agreement with 3SBio

Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizerโ€™s innovative…

ME Desk

Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…

ME Desk